0001214659-17-006341.txt : 20171102
0001214659-17-006341.hdr.sgml : 20171102
20171102142354
ACCESSION NUMBER: 0001214659-17-006341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171031
FILED AS OF DATE: 20171102
DATE AS OF CHANGE: 20171102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brister Mark
CENTRAL INDEX KEY: 0001323223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37897
FILM NUMBER: 171171734
MAIL ADDRESS:
STREET 1: C/O DEXCOM, INC.
STREET 2: 5555 OBERLIN DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OBALON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001427570
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5421 AVENIDA ENCINAS
STREET 2: SUITE F
CITY: San Diego
STATE: CA
ZIP: 92008
BUSINESS PHONE: 858-480-2400
MAIL ADDRESS:
STREET 1: 5421 AVENIDA ENCINAS
STREET 2: SUITE F
CITY: San Diego
STATE: CA
ZIP: 92008
4
1
marketforms-40047.xml
PRIMARY DOCUMENT
X0306
4
2017-10-31
0001427570
OBALON THERAPEUTICS INC
OBLN
0001323223
Brister Mark
C/O OBALON THERAPEUTICS, INC.
5421 AVENIDA ENCINAS, SUITE F
CARLSBAD
CA
92008
false
true
false
false
Chief Technology Officer
Common Stock
2017-10-31
4
A
false
1860
7.17
A
163870
D
These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
/s/ Nooshin Hussainy as attorney-in-fact for Mark Brister
2017-11-02